LENZ
【Coeptis宣布与Z Squared合并转型Dogecoin挖矿，股价暴跌近40%】 金色财经报道，Coeptis Therapeutics 将与专注于 Dogecoin 挖矿的 Z Squared 合并，并计划更名为 Z Squared，正式从生物医药公司转型为数字资产挖矿企业。此次合并将包括 9,000 台 Dogecoin 挖矿机的收购，并剥离原有的生物医药部门。受该消息影响，Coeptis 股价暴跌近 40%，当前市值约为 3,200 万美元。新公司将由 Z Squared 的现任 CEO David Halabu 与 COO Michelle Burke 领导，目标是打造美国最大的 Dogecoin 挖矿上市公司。
时间：2025-04-26 00:03:12 市场： 综合
生物技术公司Larimar Therapeutics因波动性暂停交易，停牌前下跌42%。
时间：2024-12-16 22:38:29 市场： 美股 综合
Corxel and Lenz Therapeutics Announce Positive Topline Data From China Phase 3 Presbyopia Trial of Lnz100
时间：2024-10-28 09:00:00 市场： 美股 综合
Lenz Therapeutics Announces FDA Acceptance of New Drug Application for Lnz100 for the Treatment of Presbyopia
时间：2024-10-21 20:00:00 市场： 美股 综合
University of Pennsylvania Joins Chimeric Therapeutics' Cell Therapy Clinical Trial; Shares Up 7% Chimeric Therapeutics (ASX:CHM) partnered with the University of Pennsylvania to enroll patients in the Phase 1/2 clinical trial for CHM CDH17 cell therapy in patients with advanced colorectal and gastric cancer, and intestinal neuroendocrine tumors, according to a Wednesday filing with the Australian Securities Exchange.The trial is a two-stage study aimed at determining the recommended phase 2 dose of CHM CDH17, assessing its safety and objective response rate, the filing said.Additional trial sites are expected to open for enrollment in the second half of the year.Shares rose nearly 7% in morning trade.Price (AUD): $0.02, Change: $+0.0010, Percent Change: +6.67%
时间：2024-09-11 09:26:52 市场： 美股 综合
Tyra Biosciences Names Doug Warner Chief Medical Officer Tyra Biosciences (TYRA) said late Tuesday that it has appointed Doug Warner as its chief medical officer.The company said Warner held roles with increasing responsibility over 18 years at Amgen (AMGN).Most recently, Warner was chief medical officer for eFFECTOR Therapeutics.
时间：2024-09-11 04:47:25 市场： 美股 综合